StockData
CVRx, Inc. logo

CVRx, Inc. (CVRX) stock

CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.60−0.01 (-1.15%)

Close on Nov 18, 2026Market cap $16.09MP/E –Yield –

CVRx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

CVRx's revenue for the twelve months ending Jun 30, 2026 was $61.19M, up 12.0% year over year. For fiscal 2025 it was $56.65M, up 10.4% from the year before. The highest annual figure on record is $56.65M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$56.65M+10.4%
FY2024Dec 31, 2024$51.29M+30.5%
FY2023Dec 31, 2023$39.30M+74.9%
FY2022Dec 31, 2022$22.47M+72.4%
FY2021Dec 31, 2021$13.04M+115.4%
FY2020Dec 31, 2020$6.05M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$15.71M+15.6%
Q1 FY2026Mar 31, 2026$14.77M+19.6%
Q4 FY2025Dec 31, 2025$16.02M+4.4%
Q3 FY2025Sep 30, 2025$14.69M+9.8%
Q2 FY2025Jun 30, 2025$13.59M+15.1%
Q1 FY2025Mar 31, 2025$12.35M+14.7%
Q4 FY2024Dec 31, 2024$15.34M+35.7%
Q3 FY2024Sep 30, 2024$13.37M+27.2%
Q2 FY2024Jun 30, 2024$11.81M+24.3%
Q1 FY2024Mar 31, 2024$10.77M+35.0%
Q4 FY2023Dec 31, 2023$11.31M+57.5%
Q3 FY2023Sep 30, 2023$10.51M+69.9%
Q2 FY2023Jun 30, 2023$9.50M+88.8%
Q1 FY2023Mar 31, 2023$7.98M+95.8%
Q4 FY2022Dec 31, 2022$7.18M+96.2%
Q3 FY2022Sep 30, 2022$6.19M+82.2%
Q2 FY2022Jun 30, 2022$5.03M+61.1%
Q1 FY2022Mar 31, 2022$4.08M+42.5%
Q4 FY2021Dec 31, 2021$3.66M+75.2%
Q3 FY2021Sep 30, 2021$3.40M+240.5%
Q2 FY2021Jun 30, 2021$3.12M+149.8%
Q1 FY2021Mar 31, 2021$2.86M–
Q4 FY2020Dec 31, 2020$2.09M–
Q3 FY2020Sep 30, 2020$997.00K–
Q2 FY2020Jun 30, 2020$1.25M–

More CVRx figures

See a number that looks wrong?